Natco Pharma

BSE: 524816 | NSE: NATCOPHARM
Natco Pharma (CIN: L24230TG1981PLC003201) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Apr 1995. It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills,Hyderabad,Telangana,500033.

The management team of Natco Pharma is led by Mr. V C NANNAPANENI who is the Executive Director-Chairperson. Other members of the management team consist of S V V N Appa Rao (Designation:Chief Financial Officer), Mr. T.V. RAO (Designation:Non-Executive - Independent Director), Mr. G. S. Murthy (Designation:Non-Executive - Independent Director), Mr. Rajeev Nannapaneni (Designation:Executive Director), Mr. D G Prasad (Designation:Non-Executive - Independent Director), Mrs. Leela Digumarti (Designation:Non-Executive - Independent Director), Mr. P S R K Prasad (Designation:Executive Director), Mr. M U R Naidu (Designation:Non-Executive - Independent Director), Mr. D Linga Rao (Designation:Executive Director), Mr. Sridhar Sankararaman (Designation:Non-Executive - Non Independent Director), M Adinarayana (Designation:Company Secretary & Vice President (Legal & Corporate Affairs)), .

The price and other financial information of Natco Pharma is as below -

BSE 538 -2.15 (-0.4%)

BSE

538 -2.15 (-0.4%)
Volume: 1,52,178.00
M. Cap: 9,840.00
P/E: 11.72
Prev. Close: 540.15
Day
52 Wk

NSE

533.00 -6.95 (-1.29%)
Volume: 1,31,022.00
M. Cap: 9,840.00
P/E: 11.72
Prev. Close: 539.95
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 8,66,43,105 47.38
NoOfShares 18,28,84,495 100.00
Foreign Institutions 3,91,12,525 21.39
General Public 3,37,50,705 18.45
NBFC and Mutual Funds 1,07,63,868 5.89
Others 78,84,382 4.31
ForeignPromoter 24,38,540 1.33
Financial Institutions 22,91,370 1.25
Total 36,57,68,990 200

NSE Trade Data

Trade Snapshot
VWAP 534.38
Face Value 2.00
Traded Volume (shares) 1,31,032.00
Traded Value (lacs) 700.21
Free Float Market Cap (Crs) 4,788.59
52 week high 848.30
52 week low 526.80
Lower Price Band 432.00
Upper Price Band 647.90
Security-wise Delivery Position
Quantity Traded 1,12,489.00
Deliverable Quantity (gross across client level) 70,407.00
% of Deliverable Quantity to Traded Quantity 62.59 %
Value at Risk (VaR in %)
Security VaR 5.01
Index VaR -
VAR Margin 7.50
Extreme Loss Rate 5.00
Adhoc Margin -
Applicable Margin Rate 12.50

Financial Data

Consolidated
Figures in crore 2018 2017 2016
Net Sales 2,184.80 2,020.20 1,042.30
Operating Profit 968.80 697.30 277.40
Other Income 40.40 13.90 11.80
Interest 15.40 18.50 22.90
Depreciation 66.20 54.40 50.80
Profit Before Tax 887.20 624.40 203.70
Tax 192.00 139.50 47.90
Profit After Tax 695.20 484.90 155.80
Share Capital 36.90 34.90 34.80
Reserves 3,035.30 1,614.40 1,260.90
Net Worth 3,072.20 1,649.30 1,295.70
Loans 206.40 244.50 125.90
Gross Block 1,407.60 1,158.70 983.30
Investments 76.50 32.20 22.20
Cash 183.70 35.80 45.20
Debtors 637.50 475.20 261.60
Net Working Capital 1,707.30 696.40 482.40
Operating Profit Margin (%) 44.34 34.52 26.61
Net Profit Margin (%) 31.82 24.00 14.95
Earning Per Share (Rs) 37.73 27.85 9.03
Dividend (%) 412.50 337.50 62.50
Dividend Payout 150.90 117.60 21.80
Standalone
Figures in crore 2018 2017 2016
Net Sales 2,091.30 1,958.00 1,059.20
Operating Profit 967.80 705.20 293.60
Other Income 39.40 13.20 12.90
Interest 14.70 17.50 21.90
Depreciation 65.50 53.60 50.20
Profit Before Tax 887.60 634.10 221.50
Tax 189.40 139.30 45.00
Profit After Tax 698.20 494.80 176.50
Share Capital 36.90 34.90 34.80
Reserves 3,088.50 1,664.80 1,301.50
Net Worth 3,125.40 1,699.70 1,336.30
Loans 206.20 243.50 123.50
Gross Block 1,399.60 1,151.00 975.90
Investments 149.60 94.80 93.80
Cash 172.10 25.10 40.20
Debtors 606.00 468.90 255.80
Net Working Capital 1,686.70 683.20 448.50
Operating Profit Margin (%) 46.28 36.02 27.72
Net Profit Margin (%) 33.39 25.27 16.66
Earning Per Share (Rs) 37.84 28.36 9.89
Dividend (%) 412.50 337.50 62.50
Dividend Payout 150.90 117.60 21.80
Dividend Declared (₹)
The company has declared dividend 15 times between 12 Nov 2007 and 21 Feb 2019, totaling Rs. 42.00 so far. The most dividend was declared on 21 Feb 2019 for Rs. 3.5.

Financial Data Graph

The peers of Natco Pharma are AUROPHARMA, SYNGENE and PFIZER. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.